Cite
HARVARD Citation
Sayed, A. et al. (2023). Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European journal of gastroenterology & hepatology. 35 (3), pp. 270-274. [Online].